Stay updated on LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial

Sign up to get notified when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new revision tag, v3.5.5, has been added to the record history, replacing the previous v3.5.4. This indicates an update to the page's revision documentation without altering study data or content.
    Difference
    0.1%
    Check dated 2026-06-05T22:12:34.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The study record history shows a new revision labeled v3.5.4 as the latest version, while the prior v3.5.3 label is no longer listed.
    Difference
    0.1%
    Check dated 2026-05-15T06:57:14.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page’s displayed software/UI revision label changes from v3.5.2 to v3.5.3, indicating a general platform update without altering the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:36.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:42.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and deleted revision v3.4.3 from the study record history.
    Difference
    0.1%
    Check dated 2026-03-19T04:44:50.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed on the history page.
    Difference
    0.1%
    Check dated 2026-03-11T23:00:59.000Z thumbnail image

Stay in the know with updates to LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.